| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5813613 | Neuropharmacology | 2016 | 39 Pages |
Abstract
This article is part of the Special Issue entitled 'Synaptopathy - from Biology to Therapy'.
Keywords
GluN2BmEPSCPVSTRDNMDARSSRIsketamine (PubChem CID: 3821)MPFCriluzole (PubChem CID: 5070)Rapamycin (PubChem CID: 5284616)Glutamate (PubChem CID: 33032)FSTSPTAMPARPFCECTGamma-aminobutyric acid A receptorIINSPAMERKSSTsEPMMDDAPsNMDA receptorVIPsα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptorsucrose preference testforced swim testMajor depressive disorderDepressionTreatment-resistant depressionElectroencephalographyHomeostatic synaptic plasticityInhibitory interneuronsInhibitiondisinhibitionelevated plus mazelearned helplessnessminiature excitatory post-synaptic currentElectroconvulsive therapyfast-spikingProtein synthesisRegular spikingCortexprefrontal cortexmedial prefrontal cortexpositive allosteric modulatorselective serotonin reuptake inhibitorsEEGpyramidal neuronsaction potentialsPNSKetamineGABAARGABABRAMPA receptorN-methyl-d-aspartate receptor
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Oliver H. Miller, Jacqueline T. Moran, Benjamin J. Hall,